Macquarie Group LTD Exact Sciences Corp Transaction History

Macquarie Group LTD

  • $90.3 Billion
  • Q3 2024

A detailed history of Macquarie Group LTD transactions in Exact Sciences Corp stock. As of the latest transaction made, Macquarie Group LTD holds 1,542,872 shares of EXAS stock, worth $76.1 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
1,542,872
Previous 1,541,559 0.09%
Holding current value
$76.1 Million
Previous $65.1 Million 61.3%
% of portfolio
0.12%
Previous 0.08%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$42.43 - $70.83 $55,710 - $92,999
1,313 Added 0.09%
1,542,872 $105 Million
Q2 2024

Aug 09, 2024
BUY
$41.33 - $74.26 $43.8 Million - $78.7 Million
1,059,812 Added 219.99%
1,541,559 $65.1 Million
Q1 2024

May 14, 2024
BUY
$56.27 - $73.77 $12.7 Million - $16.6 Million
225,603 Added 88.08%
481,747 $33.3 Million
Q4 2023

Feb 14, 2024
SELL
$59.06 - $75.72 $2.51 Million - $3.21 Million
-42,419 Reduced 14.21%
256,144 $18.9 Million
Q3 2023

Nov 14, 2023
SELL
$65.94 - $99.04 $2.06 Million - $3.1 Million
-31,279 Reduced 9.48%
298,563 $20.4 Million
Q2 2023

Aug 14, 2023
SELL
$62.68 - $95.05 $2.06 Million - $3.12 Million
-32,857 Reduced 9.06%
329,842 $31 Million
Q1 2023

May 15, 2023
BUY
$47.19 - $70.77 $1.43 Million - $2.14 Million
30,212 Added 9.09%
362,699 $24.6 Million
Q4 2022

Feb 21, 2023
BUY
$30.35 - $53.15 $2.07 Million - $3.63 Million
68,277 Added 25.84%
332,487 $16.5 Million
Q3 2022

Nov 14, 2022
SELL
$31.97 - $49.37 $59.2 Million - $91.4 Million
-1,851,393 Reduced 87.51%
264,210 $8.58 Million
Q2 2022

Aug 15, 2022
SELL
$35.61 - $76.23 $31 Million - $66.3 Million
-869,235 Reduced 29.12%
2,115,603 $83.3 Million
Q1 2022

May 16, 2022
BUY
$57.56 - $82.54 $70.9 Million - $102 Million
1,232,096 Added 70.3%
2,984,838 $209 Million
Q4 2021

Feb 11, 2022
SELL
$72.5 - $100.68 $38.3 Million - $53.2 Million
-528,508 Reduced 23.17%
1,752,742 $136 Million
Q3 2021

Nov 12, 2021
SELL
$90.24 - $124.05 $11.6 Million - $16 Million
-128,965 Reduced 5.35%
2,281,250 $218 Million
Q2 2021

Aug 13, 2021
BUY
$93.66 - $139.27 $15.7 Million - $23.4 Million
168,144 Added 7.5%
2,410,215 $300 Million
Q1 2021

May 14, 2021
BUY
$116.57 - $155.01 $34.8 Million - $46.3 Million
298,456 Added 15.36%
2,242,071 $295 Million
Q4 2020

Feb 16, 2021
SELL
$99.61 - $142.12 $22.1 Million - $31.6 Million
-222,138 Reduced 10.26%
1,943,615 $258 Million
Q3 2020

Nov 13, 2020
BUY
$72.92 - $102.01 $49.9 Million - $69.9 Million
684,835 Added 46.24%
2,165,753 $221 Million
Q2 2020

Aug 11, 2020
BUY
$55.75 - $92.75 $25.6 Million - $42.5 Million
458,464 Added 44.84%
1,480,918 $129 Million
Q1 2020

May 15, 2020
BUY
$37.9 - $104.44 $2.55 Million - $7.03 Million
67,271 Added 7.04%
1,022,454 $59.3 Million
Q4 2019

Feb 14, 2020
BUY
$77.66 - $99.74 $37.3 Million - $47.9 Million
479,812 Added 100.93%
955,183 $88.3 Million
Q3 2019

Nov 14, 2019
BUY
$90.37 - $122.49 $11.7 Million - $15.8 Million
128,961 Added 37.23%
475,371 $43 Million
Q2 2019

Aug 14, 2019
BUY
$89.51 - $118.04 $20.5 Million - $27 Million
228,639 Added 194.14%
346,410 $40.9 Million
Q1 2019

May 15, 2019
SELL
$61.98 - $96.5 $1.78 Million - $2.77 Million
-28,702 Reduced 19.6%
117,771 $10.2 Million
Q4 2018

Feb 15, 2019
SELL
$56.04 - $82.66 $10.2 Million - $15.1 Million
-182,168 Reduced 55.43%
146,473 $9.24 Million
Q3 2018

Nov 15, 2018
SELL
$48.29 - $80.6 $19 Million - $31.7 Million
-393,693 Reduced 54.5%
328,641 $25.9 Million
Q2 2018

Aug 14, 2018
SELL
$37.84 - $69.96 $9.09 Million - $16.8 Million
-240,259 Reduced 24.96%
722,334 $43.2 Million
Q1 2018

May 11, 2018
BUY
$39.82 - $57.53 $9.41 Million - $13.6 Million
236,415 Added 32.56%
962,593 $38.8 Million
Q4 2017

Feb 15, 2018
SELL
$46.49 - $60.51 $5.65 Million - $7.36 Million
-121,629 Reduced 14.35%
726,178 $38.2 Million
Q3 2017

Nov 08, 2017
BUY
$37.05 - $47.12 $31.4 Million - $39.9 Million
847,807
847,807 $39.9 Million

Others Institutions Holding EXAS

# of Institutions
671
Shares Held
163M
Call Options Held
2.58M
Put Options Held
2.19M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $8.73B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email